Clinical Trial Update: RNA-Loaded Dendritic Cell Cancer Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates completion of a Phase 1/Phase 2 study evaluating an RNA-loaded dendritic cell cancer vaccine for renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• RNA-Loaded Dendritic Cell Cancer Vaccine

Snippet

Sponsor: Argos Therapeutics | Conditions: Renal Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED